Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Kyma Medical Technologies, a developer of remote cardiac monitoring devices, is entertaining a $35 million acquisition offer from an unnamed suitor, according to a regulatory filing by Elron Electronic Industries, which owns a stake in Kyma.
Kyma told Elron that it inked a non-binding letter of intent with “a non-affiliated 3rd party regarding a potential acquisition of Kyma” for $35 million in cash, plus a 41/2-year earnout schedule for an unspecified series of revenue-based milestones, according to the filing. The deal would also include sales royalties for 51/2 years, Elron said, noting that it would net about $7 million if the deal is consummated. Read more
TransMedics raised a $20 million funding round for its organ preservation and transportation device, according to a regulatory filing.
Eleven unnamed investors participated in the round for Andover, Mass.-based TransMedics, according to the filing. Read more
JenaValve said that it tapped Victoria Carr-Brendel, former general manager of Boston Scientific’s Bayer Interventional business, as its new chief executive officer.
Carr-Brendel will replace Jan Keltjens, who served as interim CEO of the transcatheter aortic valve repair-focused company since January 2015. Keltjens will remain with the company as chairman of the board, JenaValve said. Read more